TCL Archive DCT Board Okays Extension Of Phase 1 Master Agreements, Increase To $4 Million February 27, 1987
TCL Archive Lasagna Committee Report Advocates Faster Drug approval, Insurance Coverage For Investigational Drugs, Ancillary Costs September 7, 1990
TCL Archive FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer April 29, 1988